Symbols

HIND

Vyome·NASDAQ

--(--)

HIND Profile

Vyome Holdings, Inc.

Emerging AI biopharmaceutical companies in the clinical stage of the US stock market

Industry

Pharmaceutical

Established Date

01/02/2008

Listing Date

10/06/2016

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.vyometx.com

Security Type

Common stock

Office address

Harvard Square, One Mifflin Place, Suite 400, Cambridge, MA 02138

Business

Introduction

Vyome Holdings, Inc., was incorporated on January 2, 2008 under the laws of the State of Delaware. The company is a clinical-stage specialty pharmaceutical company headquartered in the United States and India, focusing on the development of next-generation treatments for immune inflammation and rare diseases. Its main project, VT-1953, is a topical gel for malignant fungal wounds, while the company also sells commercialized antifungal products in India through a license agreement.